ProfileGDS4284 / 236945_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 32% 27% 32% 25% 24% 26% 29% 27% 18% 30% 27% 4% 36% 2% 35% 31% 2% 14% 36% 28% 32% 17% 42% 29% 32% 22% 33% 32% 43% 31% 38% 24% 15% 10% 38% 28% 17% 2% 23% 0% 22% 21% 30% 25% 2% 28% 32% 31% 4% 38% 18% 25% 34% 17% 22% 32% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control77.880132
GSM687648Patient 402 control63.280727
GSM687653Patient 403 control80.960132
GSM687658Patient 404 control60.707525
GSM687663Patient 411 control59.57224
GSM687668Patient 422 control60.85126
GSM687673Patient 424 control80.092129
GSM687678Patient 425 control69.475927
GSM687683Patient 427 control36.609918
GSM687688Patient 428 control79.228530
GSM687695Patient 441 control108.62827
GSM687699Patient 443 control9.973464
GSM687704Patient 444 control110.84136
GSM687707Patient 448 control7.062922
GSM687712Patient 449 control102.78335
GSM687719Patient 450 control100.98431
GSM687724Patient 451 control6.876912
GSM687728Patient 452 control25.821414
GSM687646Patient 401 treated 24h110.09136
GSM687649Patient 402 treated 24h62.569728
GSM687665Patient 411 treated 24h98.372232
GSM687651Patient 402 treated 4 weeks31.3717
GSM687667Patient 411 treated 4 weeks150.34742
GSM687670Patient 422 treated 24h77.661829
GSM687671Patient 422 treated 4 weeks84.732532
GSM687654Patient 403 treated 24h39.887922
GSM687675Patient 424 treated 24h107.22833
GSM687685Patient 427 treated 24h87.838132
GSM687656Patient 403 treated 4 weeks135.42943
GSM687677Patient 424 treated 4 weeks84.242831
GSM687687Patient 427 treated 4 weeks109.92738
GSM687692Patient 428 treated 4h53.201324
GSM687716Patient 449 treated 4h28.624615
GSM687722Patient 450 treated 4h22.209910
GSM687680Patient 425 treated 24h118.83238
GSM687690Patient 428 treated 24h67.930628
GSM687700Patient 443 treated 24h52.868917
GSM687705Patient 444 treated 24h5.839692
GSM687714Patient 449 treated 24h46.664823
GSM687721Patient 450 treated 24h2.669250
GSM687682Patient 425 treated 4 weeks46.02322
GSM687694Patient 428 treated 4 weeks39.227521
GSM687702Patient 443 treated 4 weeks86.313530
GSM687718Patient 449 treated 4 weeks59.518825
GSM687723Patient 450 treated 4 weeks6.531152
GSM687661Patient 404 treated 4h73.344528
GSM687710Patient 448 treated 4h88.537732
GSM687726Patient 451 treated 4h101.19431
GSM687730Patient 452 treated 4h26.16674
GSM687660Patient 404 treated 24h156.78438
GSM687697Patient 441 treated 24h50.574618
GSM687709Patient 448 treated 24h61.803625
GSM687725Patient 451 treated 24h125.44634
GSM687729Patient 452 treated 24h48.374317
GSM687727Patient 451 treated 4 weeks55.289422
GSM687731Patient 452 treated 4 weeks101.62832